Human Relevant,
But No Animals
We engineer biofabricated human tissues and organoids to help pharma and biotech reduce R&D risk, accelerate development timelines, and replace animal models with human-relevant data.
Company Overview
Biodimension is a pioneering tissue engineering company that specializes in the development of biofabricated human tissues and organoids. Our innovative approach revolutionizes the way pharmaceutical and biotechnology companies conduct research and development.
We focus on creating non-animal drug screening platforms that provide more accurate, human-relevant data. Our biofabricated tissues serve as predictive models that help researchers understand drug efficacy and safety before clinical trials.
With a commitment to innovation and ethical practices, Biodimension is transforming the landscape of drug discovery and development, making it more efficient, reliable, and humane.
Revolutionizing Healthcare
Our vision is to revolutionize healthcare by becoming a leading organ manufacturer through our advanced tissue engineering techniques, making organ transplantation accessible to everyone worldwide.
Enhancing Drug Discovery
Our mission is to enhance the drug discovery process and promote the safety and efficacy testing of cosmetics and chemicals through innovative biofabricated human tissue models.
Our Story
2020
Ideation stage company – Founded with vision to revolutionize tissue engineering
Vision to revolutionize healthcare
Tissue engineering focus
2021
Major milestones including company incorporation, incubation at VITTBI, and government support from DST.
DST recognition and funding
BioDEpi human skin epidermis
2022
Expansion phase with HSI India partnership, BIRAC grant, R&D facility establishment, and DANA CSR grant.
HSI India collaboration
Own facility at Vellore
2023
Global expansion with DIT UK program, new product variants, and facility expansion to Bangalore.
DIT UK partnership
BioDFT and variants
2024
Foundation of innovation with advanced product pipeline, national policy recognition, and significant funding milestones.
10 scientists, 50+ years expertise
CDSCO stakeholder recognition
2025
World-class infrastructure launch, capacity scaling, IP milestones, and clinical expansion partnerships.
200 units per cycle capacity
3 patents in pipeline
Starting as an ideation stage company, we've grown through key milestones including incorporation, incubation, government support, product launches, facility expansion, funding rounds, IP development, and clinical partnerships, becoming a leader in tissue engineering and biofabrication.
Executive Leadership Team
Meet the visionary leaders driving innovation in tissue engineering and biofabrication.
Manojkumar Sampathkumar
Founder and CEO
Leads innovation, production, and scientific team building.Advances R&D in tissue engineering and product development.Aligns solutions to healthcare and regulatory needs.
Pradeep Arunachalam
Founder and CXO
oversees corporate affairs, finance, compliance, and quality systems. With over a decade of experience, he drives operational excellence, regulatory alignment, and investor confidence to strengthen Biodimension’s NAMs platforms.
Ranjith Kumar Velusamy
Founder and CIO
Drives business development, marketing, sales, and investor relations.Builds strategic partnerships and market presence for Biodimension.Ensures global adoption of NAMs and organoid platforms.
Our Pillars
The key experts and specialists who form the foundation of our research and development excellence.
ChiragKumar H. Rasbhara
Senior Scientist
Expert in tissue engineering and regenerative medicine, ChiragKumar leads the development of advanced tissue constructs and innovative research projects at BioDimension.
Mohanya Kumaravel
Scientist II
Mohanya specializes in bioengineering and bioprocess optimization, driving the implementation of cutting-edge technologies for tissue model fabrication and quality improvement.
Rajashree S
Scientist II
Rajashree focuses on cell culture and tissue model validation, ensuring the scientific rigor and reproducibility of our organoid and tissue engineering platforms.
Dr Dhara Jajal
Scientist III
With a strong background in molecular biology and tissue analysis, Dr. Dhara advances our research in human-relevant models and supports new assay development.
Sabari Debnath
Research Assistant
Sabari supports laboratory operations, assisting in experimental setups, data collection, and maintaining high standards in research execution.
Rajasekar P N
Business Development Executive
Rajasekar bridges science and business, managing client relationships, outreach, and supporting the growth of BioDimension’s innovative solutions in the market.
What Our Clients Say
Hear from those who trust our solutions
Loading Testimonials
Fetching client feedback...
Start Your Journey withBioDimension Today
Join hundreds of leading researchers and pharmaceutical companies who trust our biofabricated tissue models for their most critical research and development projects.